Evan Hecker

Title: The Innovative Contributions of Evan Hecker

Introduction

Evan Hecker is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of pharmaceuticals. With a total of 6 patents to his name, Hecker's work focuses on developing new crystalline forms of tebipenem pivoxil, which have important implications for treating antibiotic-resistant bacterial infections.

Latest Patents

Hecker's latest patents include a range of new crystalline tebipenem pivoxil salt forms. These include a crystalline tebipenem pivoxil ethane sulfonate salt form (Form A), a crystalline tebipenem pivoxil ketoglutarate salt form (Form A), and tebipenem pivoxil maleate salt forms (Form A and Form B). Additionally, he has developed a tebipenem pivoxil malate salt form (Form A), a tebipenem pivoxil methane sulfonate salt form (Form B), a tebipenem pivoxil hydrobromide salt form (Form B), and a tebipenem pivoxil edisylate salt form (Form A). His disclosures also include a composition that comprises a crystalline tebipenem pivoxil salt and a pharmaceutically acceptable carrier, along with methods for treating antibiotic-resistant infections.

Career Highlights

Evan Hecker has worked with prominent organizations such as Spero Therapeutics, Inc. and Harvard College. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Hecker has collaborated with notable colleagues, including Akash Jain and Richard Edwards, which has further enriched his innovative endeavors.

Conclusion

Evan Hecker's contributions to the field of pharmaceuticals, particularly through his patents on tebipenem pivoxil crystalline forms, highlight his role as a significant inventor. His work not only advances scientific knowledge but also addresses critical health challenges.